Altered manganese homeostasis: Implications for BLI-3-dependent dopaminergic neurodegeneration and SKN-1 protection in C. elegans

ATSDR, 2008 Aschner, 2005, Nutritional aspects of manganese homeostasis, Mol Aspects Med, 26, 353, 10.1016/j.mam.2005.07.003 Dobson, 2004, Manganese neurotoxicity, Ann N Y Acad Sci, 1012, 115, 10.1196/annals.1306.009 Touret, 2003, Dynamic traffic through the recycling compartment couples the metal transporter Nramp2 (DMT1) with the transferrin receptor, J Biol Chem, 278, 25548, 10.1074/jbc.M212374200 Au, 2008, Manganese transport in eukaryotes: the role of DMT1, Neurotoxicology, 29, 569, 10.1016/j.neuro.2008.04.022 Lockman, 2001, Inhibition of the rat blood–brain barrier choline transporter by manganese chloride, J Neurochem, 79, 588, 10.1046/j.1471-4159.2001.00589.x Crossgrove, 2003, Manganese distribution across the blood–brain barrier. I. Evidence for carrier-mediated influx of manganese citrate as well as manganese and manganese transferrin, Neurotoxicology, 24, 3, 10.1016/S0161-813X(02)00089-X Goytain, 2008, Huntingtin-interacting proteins. HIP14 and HIP14L, mediate dual functions, palmitoyl acyltransferase and Mg2+ transport, J Biol Chem, 283, 33365, 10.1074/jbc.M801469200 Gitler, 2009, Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity, Nat Genet, 41, 308, 10.1038/ng.300 Gunshin, 1997, Cloning and characterization of a mammalian proton-coupled metal-ion transporter, Nature, 388, 482, 10.1038/41343 Andrews, 1999, The iron transporter DMT1, Int J Biochem Cell Biol, 31, 991, 10.1016/S1357-2725(99)00065-5 Huang, 2004, Distribution of divalent metal transporter-1 in the monkey basal ganglia, Neuroscience, 128, 487, 10.1016/j.neuroscience.2004.06.055 Salazar, 2008, Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease, Proc Natl Acad Sci U S A, 105, 18578, 10.1073/pnas.0804373105 Sriram, 2010, Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes, Arch Toxicol, 84, 521, 10.1007/s00204-010-0525-9 He, 2011, DMT1 polymorphism and risk of Parkinson's disease, Neurosci Lett, 501, 128, 10.1016/j.neulet.2011.07.001 Leung, 2008, Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology, Toxicol Sci, 106, 5, 10.1093/toxsci/kfn121 Brenner, 1974, The genetics of Caenorhabditis elegans, Genetics, 77, 71, 10.1093/genetics/77.1.71 Sulston, 1975, Dopaminergic neurons in the nematode Caenorhabditis elegans, J Comp Neurol, 163, 215, 10.1002/cne.901630207 Garrick, 2003, DMT1: a mammalian transporter for multiple metals, Biometals, 16, 41, 10.1023/A:1020702213099 Au, 2009, SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans, PLoS One, 4, e7792, 10.1371/journal.pone.0007792 Benedetto, 2010, Extracellular dopamine potentiates Mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans, PLoS Genet, 6, 10.1371/journal.pgen.1001084 Nass, 2005, A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking, J Neurochem, 94, 774, 10.1111/j.1471-4159.2005.03205.x Jomova, 2011, Advances in metal-induced oxidative stress and human disease, Toxicology, 283, 65, 10.1016/j.tox.2011.03.001 Sistrunk, 2007, Direct effects of manganese compounds on dopamine and its metabolite Dopac: an in vitro study, Environ Toxicol Pharmacol, 23, 286, 10.1016/j.etap.2006.11.004 Thein, 2009, Combined extracellular matrix cross-linking activity of the peroxidase MLT-7 and the dual oxidase BLI-3 is critical for post-embryonic viability in Caenorhabditis elegans, J Biol Chem, 284, 17549, 10.1074/jbc.M900831200 Wu, 2003, NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease, Proc Natl Acad Sci U S A, 100, 6145, 10.1073/pnas.0937239100 Oliveira, 2009, Condition-adapted stress and longevity gene regulation by Caenorhabditis elegans SKN-1/Nrf, Aging Cell, 8, 524, 10.1111/j.1474-9726.2009.00501.x Choi, 2012, NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease, Antioxid Redox Signal, 16, 1033, 10.1089/ars.2011.3960 Kumar, 2012, Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity, Brain Res, 1438, 48, 10.1016/j.brainres.2011.12.028 Cristovao, 2009, The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death, Antioxid Redox Signal, 11, 2105, 10.1089/ars.2009.2459 Migheli, 1999, Enhancing effect of manganese on l-DOPA-induced apoptosis in PC12 cells: role of oxidative stress, J Neurochem, 73, 1155, 10.1046/j.1471-4159.1999.0731155.x Chan, 2011, l-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro, Exp Neurol, 10.1016/j.expneurol.2011.09.029 Barone, 2011, Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease, Dis Model Mech, 4, 701, 10.1242/dmm.007575 Bandyopadhyay, 2009, Functional assessment of Nramp-like metal transporters and manganese in Caenorhabditis elegans, Biochem Biophys Res Commun, 390, 136, 10.1016/j.bbrc.2009.09.082 Hoeven, 2011, Ce-Duox1/BLI-3 generated reactive oxygen species trigger protective SKN-1 activity via p38 MAPK signaling during infection in C. elegans, PLoS Pathog, 7, e1002453, 10.1371/journal.ppat.1002453 Mosley, 2012, Inflammation and adaptive immunity in Parkinson's disease, Cold Spring Harb Perspect Med, 2, a009381, 10.1101/cshperspect.a009381